Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

June 6, 2024

Study Completion Date

June 30, 2026

Conditions
Metastatic Breast Cancer
Interventions
OTHER

Treatment recommendation

Depending on the results from the participant's archival tissue, a panel of Johns Hopkins investigators will meet to interpret the molecular and genetic profiling results in order to identify any actionable mutations to provide a personalized treatment recommendation for the patient.

Trial Locations (2)

15212

Allegheny Health Network Cancer Institute, Pittsburgh

21287-0013

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

Sponsors
All Listed Sponsors
collaborator

Foundation Medicine

INDUSTRY

collaborator

Avon Foundation

OTHER

collaborator

Biocept, Inc.

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER